Related Experiment Video
Updated: May 19, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Antimicrobial drug interactions in the critically ill patients
1Emergency and Intensive Care Department, Centro Hospitalar S. Joao EPE, Faculdade de Medicina do Porto, Al Prof Hernani Monteiro, Porto, Portugal. jmcrpereira@yahoo.com
Current Clinical Pharmacology
|September 6, 2012
Summary
Critically ill patients often take multiple medications, increasing the risk of dangerous drug interactions. This review highlights key antimicrobial drug interactions in the Intensive Care Unit (ICU) to improve patient safety.
Area of Science:
- Pharmacology
- Critical Care Medicine
- Infectious Diseases
Background:
- Critically ill patients in the Intensive Care Unit (ICU) frequently receive multiple medications (polymedication).
- This polymedication strategy places them at a significant risk for potential drug interactions.
- Infections are common in ICUs, necessitating antimicrobial therapy for many patients.
Purpose of the Study:
- To review and describe significant drug interactions involving antimicrobials in critically ill patients.
- To emphasize the importance of understanding these interactions for optimizing antimicrobial effectiveness.
- To reduce the incidence of adverse drug events in the ICU population.
Main Methods:
- Literature review of drug interactions involving antimicrobials.
- Focus on critically ill patient populations within the Intensive Care Unit setting.
- Analysis of clinical consequences and impact on treatment outcomes.
Main Results:
- Identified several clinically relevant drug interactions between commonly used antimicrobials and other ICU medications.
- Drug interactions can alter antimicrobial efficacy and increase the risk of adverse events.
- The severity of consequences ranges from mild to life-threatening.
Conclusions:
- Awareness of antimicrobial drug interactions is crucial for safe and effective patient care in the ICU.
- Healthcare providers must carefully consider potential interactions when prescribing multiple drugs to critically ill patients.
- Further research and clinical vigilance are needed to manage and prevent adverse drug events stemming from these interactions.
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...